​
​

Poseida Therapeutics Ownership | Who Owns Poseida Therapeutics?

OverviewForecastRevenueFinancialsChart

Poseida Therapeutics Ownership Summary

Poseida Therapeutics is owned by 55.14% institutional investors, 27.64% insiders, and 17.22% retail investors. Fmr is the largest institutional shareholder, holding 15.15% of PSTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.57% of its assets in Poseida Therapeutics shares.

PSTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPoseida Therapeutics55.14%27.64%17.22%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S4.44M4.57%29.37K
Fidelity Growth Compy Commingled Pl O4.41M4.54%12.03K
Fidelity Growth Company Fund3.48M3.59%-7.40K
Fidelity Select Health Care2.39M2.46%-
Vanguard Total Stock Mkt Idx Inv2.14M2.20%-
iShares Russell 2000 ETF1.71M1.76%-3.84K
Fidelity Advisor Health Care I1.45M1.50%-
Fidelity Growth Company K61.27M1.31%-21.98K
Vanguard Institutional Extnd Mkt Idx Tr993.34K1.02%-
Fidelity Series Growth Company937.36K0.96%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 08, 2022Malin Life Sciences Holdings Ltd Buy$7.53M
Aug 08, 2022Ostertag Eric Executive ChairmanBuy$500.00K
Aug 03, 2022Ostertag Eric Executive ChairmanSell$592.81K
Mar 16, 2022Ingalls Kerry D. Chief Operating OfficerBuy$11.94K
Dec 06, 2021Malin Life Sciences Holdings Ltd-Buy$12.61K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q2--
2023 Q1--
2022 Q4--

PSTX Ownership FAQ

Who Owns Poseida Therapeutics?

Poseida Therapeutics shareholders are primarily institutional investors at 55.14%, followed by 27.64% insiders and 17.22% retail investors. The average institutional ownership in Poseida Therapeutics's industry, Biotech Stocks , is 45.35%, which Poseida Therapeutics exceeds.

Who owns the most shares of Poseida Therapeutics?

Poseida Therapeutics’s largest shareholders are Fmr (14.54M shares, 15.15%), Pentwater capital management lp (5.98M shares, 6.22%), and Blackrock (4.91M shares, 5.11%). Together, they hold 26.48% of Poseida Therapeutics’s total shares outstanding.

Does Blackrock own Poseida Therapeutics?

Yes, BlackRock owns 5.11% of Poseida Therapeutics, totaling 4.91M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.32M$. In the last quarter, BlackRock decreased its holdings by -44.91K shares, a -0.91% change.

Who is Poseida Therapeutics’s biggest shareholder by percentage of total assets invested?

Silverarc capital management is Poseida Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.49% of its assets in 3.61M Poseida Therapeutics shares, valued at 10.54M$.

Who is the top mutual fund holder of Poseida Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Poseida Therapeutics shares, with 4.57% of its total shares outstanding invested in 4.44M Poseida Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools